Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale (EPIC-FOP)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by University Hospital, Brest
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT01216423
First received: September 29, 2010
Last updated: November 3, 2014
Last verified: November 2014

September 29, 2010
November 3, 2014
November 2009
November 2014   (final data collection date for primary outcome measure)
Incidence of recent ischemic stroke in patients hospitalized for a recent pulmonary embolism with comparison in two groups with and without PFO [ Time Frame: 7 days ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT01216423 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Pulmonary Embolism and Stroke in Patient With Patent Foramen Ovale
Is There a Link Between Venous Thromboembolism and Stroke in Patient With Patent Foramen Ovale ? Research for Stroke in Hospitalized Patients With Pulmonary Embolism.

The cause of ischemic stroke remains frequently unknown. In patients with patent foramen ovale (PFO), the link between PFO and Stroke is unclear. The investigators hypothesize that the main mechanism is paradoxical embolism and decided to look for clinically apparent and silent cerebral embolism in patients with a recent pulmonary embolism.

Inclusion criteria :

  • age > 18 years old
  • confirmed pulmonary embolism
  • informed consent
  • social ensured

Exclusion criteria :

  • pregnancy
  • age < 18 years old
  • protected major person (in sense of public health)
  • consent refused
  • MRI contraindications
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Consecutive series of hospitalized patients with pulmonary embolism

  • Recent Stroke
  • Pulmonary Embolism
  • Patent Foramen Ovale
Not Provided
  • Incidence of recent stroke in patients with PFO
  • Incidence of recent stroke in patients without PFO
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
297
December 2015
November 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age > 18 years old
  • confirmed pulmonary embolism
  • informed consent
  • social ensured

Exclusion Criteria:

  • pregnancy
  • age < 18 years old
  • protected major person (in sense of public health)
  • consent refused
  • MRI contraindications
Both
18 Years and older
No
Contact: Emmanuelle Le Moigne, MD +33298347336 emmanuelle.lemoigne@chu-brest.fr
France
 
NCT01216423
EPIC-FOP
Yes
University Hospital, Brest
University Hospital, Brest
Not Provided
Principal Investigator: Emmanuelle LE MOIGNE, MD University Hospital, Brest
University Hospital, Brest
November 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP